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University, Maastricht, The NetherlandsA B S T R A C TObjective: To assess the cost-effectiveness of screening 50- to 70-
year-old adults for hearing loss in The Netherlands. We compared no
screening, telephone screening, Internet screening, screening with a
handheld screening device, and audiometric screening for various
starting ages and a varying number of repeated screenings. Methods:
The costs per quality-adjusted life-year (QALY) for no screening and
for 76 screening strategies were analyzed using a Markov model with
cohort simulation for the year 2011. Screening was deemed to be cost-
effective if the costs were less than €20,000/QALY. Results: Screening
with a handheld screening device and audiometric screening were
generally more costly but less effective than telephone and Internet
screening. Internet screening strategies were slightly better than
telephone screening strategies. Internet screening at age 50 years,ee front matter Copyright & 2015, International S
r Inc.
.1016/j.jval.2015.03.1789
ssen@mumc.nl.
ondence to: Anouk M. Linssen, Department of Oto
. Box 5800, 6202 AZ Maastricht, The Netherlands.repeated at ages 55, 60, 65, and 70 years, was the most cost-effective
strategy, costing €3699/QALY. At a threshold of €20,000/QALY, this
strategy was with 100% certainty cost-effective compared with cur-
rent practice and with 69% certainty the most cost-effective strategy
among all strategies. Conclusions: This study suggests that Internet
screening at age 50 years, repeated at ages 55, 60, 65, and 70 years, is
the optimal strategy to screen for hearing loss and might be consid-
ered for nationwide implementation.
Keywords: adults, cost-effectiveness, hearing loss, Markov model,
screening.
Copyright & 2015, International Society for Pharmacoeconomics and
Outcomes Research (ISPOR). Published by Elsevier Inc.Introduction
Untreated hearing loss has various negative consequences,
including social isolation, loneliness, psychosocial distress, anxi-
ety, and depression [1–3]. Hearing aid ﬁtting can increase the
quality of life of people with a hearing loss [4–6]. It is a cost-
effective intervention (compared with no rehabilitation) [7,8].
Nevertheless, adults generally postpone seeking help until 5 to
10 years after the onset of their hearing loss [9–11]. People mainly
postpone seeking help because they are unaware or in denial of
the hearing loss and believe they can still manage without
hearing aids [12].
Seeking help at an early stage is important because adults
who start using hearing aids early—that is, at a relatively young
age or when their hearing loss is still relatively mild—do not only
have more years with beneﬁt ahead but also have greater beneﬁt
from their hearing aids during later life than do adults who start
using hearing aids late [9]. This can be explained by the fact that
older adults have more difﬁculty adapting to hearing aids and
learning to use new technology because of poorer cognitive
performance and poorer learning ability [13,14]. Moreover, peoplewith poorer cognitive performance often have difﬁculty in for-
mulating their needs during a hearing aid trial, which can result
in a suboptimal hearing aid ﬁt [15].
Adult hearing screening is thought to motivate people to seek
help earlier. Studies in the United Kingdom showed that screen-
ing can triple hearing aid ownership among middle-aged adults
[16,17]. The only randomized controlled trial of the effectiveness
of screening so far showed that screening with an objective
measurement instrument can almost double the 1-year incidence
of hearing aid use [18]. Adult hearing screening is found to be a
cost-effective intervention to increase hearing aid use and quality
of life (in comparison with no screening) [19,20]. Screening with
an objective measurement instrument outperformed screening
with a subjective measurement instrument (questionnaire) and
screening with an objective and subjective instrument combined
[19,20]. Our study is the ﬁrst that assessed the costs and the
effects on quality of life of telephone and Internet screening. The
costs and effects were compared with those of screening with a
handheld screening device (like Liu et al. [19]), screening with an
audiometer (like Morris et al. [20]), and current practice in The
Netherlands (no nationwide adult hearing screening program).ociety for Pharmacoeconomics and Outcomes Research (ISPOR).
rhinolaryngology, Head and Neck Surgery, Maastricht University
V A L U E I N H E A L T H 1 8 ( 2 0 1 5 ) 5 6 0 – 5 6 9 561Methods
Model Structure
A Markov model was constructed to evaluate the cost-
effectiveness of adult hearing screening from a health care
perspective. All costs were in euros (€1.00 is US $1.38 and £0.87,
average 2011 conversion rates). The effectiveness measure in the
model was the quality-adjusted life-year (QALY), which is a
combined measure of health-related quality of life and duration
of life. The model allowed simulating the lifetime course of
events in 50-year-old adults who do not own hearing aids.
Possible events included hearing deterioration, hearing aid
uptake, hearing aid replacement, hearing aid discard, and dying.
The health states of the model were based on hearing loss
severity and hearing aid use (Fig. 1). For hearing loss severity,
the classiﬁcation of the World Health Organization was used,
with a hearing threshold (pure-tone average at 0.5, 1, 2, and 4
kHz) between 25 and 40 dB in the best ear indicating mild hearing
impairment and a hearing threshold of more than 40 dB in the
best ear indicating moderate to severe hearing impairment.
A hearing threshold of 25 dB or less in the best ear indicated
either normal hearing or unilateral hearing impairment. With
unilateral hearing impairment, we refer to a hearing threshold of
25 dB or less in the best ear, a hearing threshold of more than 25
dB in the worst ear, and an interaural difference of 10 dB or more
at three frequencies, 15 dB or more at two frequencies, or 20 dB or
more at one frequency. Approximately 27% of the people with a
hearing threshold of 25 dB or less in the best ear have unilateral
hearing impairment [21]. We assumed that among adults with a
hearing threshold of 25 dB or less in the best ear, only adults with
unilateral hearing impairment might take up hearing aids. We
did not consider, however, normal hearing and unilateral hearing
impairment as separate health states in our model because data
on the annual probability to develop mild hearing impairment for
these two groups separately were not available.
The model simulated current practice (no screening) and four
types of nationwide screening:1.Fig
he
(gr
beTelephone screening: The target population is invited by letter to
undertake the National Hearing Test by telephone. The National
Hearing Test is a fully automatic adaptive speech-in-noise test
that uses digit-triplets as speech material. It was developed and
validated by Smits et al. [22]. There are three possible outcomes:
good, insufﬁcient, and poor hearing. People with insufﬁcient or
poor hearing are considered screen-positive. Because only one
ear is tested (usually the participant’s best ear), the test is unable
to detect unilateral hearing impairment.. 1 – General structure of the Markov model. The solid and da
aring deterioration (bold black lines), hearing aid uptake (thin
ay lines). Screening is offered to people without hearing aids a
st-ear pure-tone average (0.5, 1, 2, and 4 kHz); HA, hearing ai2.she
bl
nd
d; HInternet screening: The target population is invited by letter to
take the Internet version of the National Hearing Test (www.
hoortest.nl). The test was developed by Smits et al. [23] and
validated by Leensen et al. [24]. It is greatly similar to the
telephone test, except for the fact that the Internet test
presents the signals to both ears simultaneously. The Internet
test will not detect unilateral hearing impairment.3. HearCheck screening: Members from the target population who
visit the practice of the general practitioner (GP), for whatever
reason, are offered a hearing screening test while waiting for a
consultation with their GP. The GP assistant performs the
screening using the Siemens HearCheck Navigator. The Sie-
mens HearCheck Navigator is a handheld screening device
that emits ﬁve tones: 375 (35 dB), 1000 (55 and 35 dB), and 3000
Hz (75 and 35dB). Depending on which tones are heard, the
test will inform the participants whether their hearing in the
tested ear is good, insufﬁcient, or poor. Both ears are tested
separately; therefore, unilateral hearing impairment can be
detected. People with insufﬁcient or poor hearing in one or
both ears are considered screen-positive. The GP discusses the
outcome with everyone who screened positive.4. Audiometric screening: Members from the target population
who visit the GP practice, for whatever reason, are offered a
hearing screening test while waiting for a consultation with
their GP. The GP assistant performs standard pure-tone
audiometry. Because this is the criterion standard, everyone
with hearing impairment is screen-positive and everyone
with normal hearing is screen-negative. The GP discusses
the outcome with everyone who screened positive.
In total, 76 screening strategies were included in the economic
evaluation. The strategies were varied in the type of screening,
the age at ﬁrst screening (either 50, 55, 60, 65, or 70 years), the
number of repeated screenings (up to ﬁve repetitions), and the
time interval between repeated screenings (either 5 or 10 years).
The model was constructed using Microsoft Excel 2010 with
customized macros and had a lifetime time horizon with a cycle
length of 1 year.Model Input
In the paragraphs below we brieﬂy describe which parameters
were accounted for in the model. An elaborate description of our
considerations, calculations, and assumptions with regard to the
parameter estimates is given in the Appendix in Supplemental
Materials found at http://dx.doi.org/10.1016/j.jval.2015.03.1789.
Appendix Table A1 in Supplemental Materials found at http://
dx.doi.org/10.1016/j.jval.2015.03.1789 lists the model parameterd lines represent the transitions to other health states by
ack lines), hearing aid discard (dashed lines), and dying
affects only the probability of hearing aid uptake. BEPTA,
I, hearing impairment; mod, moderate; sev, severe.
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in current practice, including base-case parameter estimates,
distributions, and references to data sources. Appendix Table
A2 in Supplemental Materials found at http://dx.doi.org/10.1016/j.
jval.2015.03.1789 lists the additional model input for screening-
speciﬁc parameters.
Transition Probabilities
At model entrance, the cohort comprised adults without hearing
aids who were distributed over the three possible starting states
on the basis of the prevalence of uncorrected mild and moderate
to severe hearing impairment in the general population [25].
Hearing deterioration was modeled using estimates of the 1-year
incidence of mild and moderate to severe hearing impairment
that were, like the prevalence data, derived from the Blue
Mountains Hearing Study [25]. We used age- and sex-speciﬁc
annual mortality ﬁgures from the Dutch life tables [26]. The
probability of hearing aid discard was set at 6% in all strategies
[27]. We modeled that screening would be offered exclusively to
people without hearing aids and that it would inﬂuence only the
probability of hearing aid uptake (thin black arrows in Fig. 1). The
probability of hearing aid uptake was modeled separately for
current practice and for each screening strategy as a function of
the following parameters: the probability of screen participation,
the validity of the screening test, the probability of help-seeking
(ﬁrst step), the probability that a help-seeker continues help-
seeking, the probability that someone who continued help-
seeking starts a hearing aid trial, and the probability that the
trial is ended successfully and thus resulted in hearing aid
purchase. The screening strategies differed in the probability of
screen participation, the validity of the screening test, the
probability of help-seeking, and the probability of continued
help-seeking. Estimates of these screening-speciﬁc probabilities
and the sources on which they were based can be found in the
Appendix (pages 2 and 3 and Appendix Table A2 in Supplemental
Materials). The probability that someone who continued help-
seeking starts a hearing aid trial and the probability of trial success
were assumed not to be inﬂuenced by screening. For adults who
did not participate in screening, we used the probabilities of help-
seeking and continued help-seeking from current practice.
In The Netherlands, the ﬁrst step in help-seeking for hearing
impairment is a consultation with either the GP or the hearing
aid dispenser. Continued help-seeking may include a consulta-
tion with the ear, nose, and throat (ENT) specialist, a consultation
at the audiological center, and/or an intake meeting with the
hearing aid dispenser (see Appendix Fig. A1 in Supplemental
Materials found at http://dx.doi.org/10.1016/j.jval.2015.03.1789 for
a schematic overview of possible paths in continued help-seek-
ing). The ENT specialist clinically examines the ear, removes
earwax, diagnoses ear pathology, performs hearing tests, informs
the help-seeker about treatment possibilities, and prescribes
hearing aids to those who are willing to try them. Furthermore,
the ENT specialist refers help-seekers to the audiological center
in case of a need for additional counseling, problems in accepting
hearing impairment, limited willingness to use hearing aids,
severe hearing loss, poor speech discrimination, and the pres-
ence of additional sensory or mental disability. The hearing aid
dispenser is responsible for hearing aid ﬁtting and is the only
hearing care professional who sells hearing aids.
Costs and Quality-of-Life Input
The following costs were included in the analysis: costs of
consultations with the GP assistant, GP, ENT specialist, hearing
aid dispenser, and employees of the audiological center (clinical
physicist/audiologist, audiology assistant, social worker, andspeech therapist); costs of hearing aids and hearing aid batteries,
maintenance, and repair; costs of the invitation letter for tele-
phone and Internet screening; telephone costs; Web hosting costs
for the Internet test; costs of the disposable ear cups for the
HearCheck Navigator; and annual depreciation and maintenance
costs of the HearCheck Navigator and audiometer used for
screening. Price indices were used to convert costs to a 2011
price level [26].
Health-related quality of life was expressed as a utility score
between 0 (death) and 1 (perfect health). Data on utility scores in
relation to hearing thresholds and hearing aid ﬁtting, measured
with the Health Utility Index Mark 3 questionnaire, were col-
lected by our research group in 2004 [28]. We reanalyzed these
data to obtain age-dependent utility scores for each of the health
states. Details of this analysis can be found on pages 3 and 4 of
the Appendix in Supplemental Materials.
Analyses
We examined the expected costs and effects of current practice
and the 76 screening strategies for adults without hearing aids
using cohort simulation. Future costs were discounted at an
annual rate of 4.0%, and future effects were discounted with an
annual rate of 1.5% following the Dutch guidelines [29]. To
account for uncertainty in the model parameter estimates, we
performed probabilistic sensitivity analysis using Monte-Carlo
simulation with 10,000 iterations. For each iteration, parameter
values were drawn at random from the distribution around the
base-case estimates. See Appendix Tables A1 and A2 in Supple-
mental Materials for the assigned distributions.
We sorted the strategies from lowest to highest expected costs
(based on the results of the probabilistic sensitivity analysis) and
calculated the incremental costs and incremental QALYs of each
strategy compared with current practice (no screening). Incre-
mental cost-effectiveness ratios (ICERs) were calculated by divid-
ing the incremental costs by the incremental QALYs. The
sequence of strategies, from lowest costs to highest, that gives
the lowest ICER values forms the cost-effectiveness frontier [30].
In a cost-effectiveness plane with the incremental costs of all
strategies plotted against their incremental QALYs, the cost-
effectiveness frontier is the line that connects the strategies that
dominate or extendedly dominate the other strategies. A strategy
is dominated by another strategy if it is more costly and less
effective. A strategy is extendedly dominated if it is more costly,
or less effective and has a higher ICER than does a more effective
strategy. The optimal strategy is the strategy on the cost-
effectiveness frontier that has the highest ICER below an exter-
nally set cost-effectiveness threshold or ceiling ratio (λ). In The
Netherlands, λ for screening is set at €20,000/QALY, which means
that a screening strategy will be considered for nationwide
implementation only if the costs per QALY gained are less than
€20,000 [31].
To graphically illustrate the uncertainty concerning the cost-
effectiveness of the strategies, a cost-effectiveness acceptability
frontier (CEAF) was constructed on the basis of results of the
probabilistic sensitivity analysis [32]. For construction of the
CEAF, the net monetary beneﬁt of the strategies was calculated
for a range of λ values using the following formula: net monetary
beneﬁt ¼ λ  QALY  costs. For every value of λ, the optimal
strategy was identiﬁed (i.e., the strategy with the highest mean
net monetary beneﬁt for each of the 10,000 iterations). Next, the
probability for the optimal strategy to be the most cost-effective
strategy at a certain value of λ was calculated as the proportion of
iterations in which the optimal strategy had the highest net
monetary beneﬁt. The CEAF shows the optimal strategies and
their probability of cost-effectiveness for λ values between €0/
QALY and €20,000/QALY.
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In the base-case analysis, the probability of screen participation
was 0.33 for telephone screening and 0.44 for Internet screening
(both estimates were derived from a study by Koopman et al.
[33]). We performed a one-way sensitivity analysis to determine
whether the results would have been different if the probability
of screen participation for Internet screening had been 0.33 as
well (one-way sensitivity analysis 1). For screen-positive adults
with moderate to severe hearing impairment, the probability of
help-seeking after telephone and Internet screening was 0.81 and
0.79, respectively, according to Koopman et al. [33]. Smits et al.
[23] reported a probability of 0.57. A second sensitivity analysis
was performed to determine whether the results would have
been different if Smits et al.’s instead of Koopman et al.’s
estimates had been used (one-way sensitivity analysis 2). In the
base-case analysis, we assumed that the probability that some-
one who sought help after telephone or Internet screening
continues help-seeking would be 25% higher (relative increase)
than the probability of continued help-seeking in current prac-
tice. An increase is to be expected, but the size of this increase
was an arbitrary choice. With a third sensitivity analysis we
examined whether the results would have been different if the
relative increase had been set at 10% instead of 25% (one-way
sensitivity analysis 3). A rescreen after 5 years is less effective in
stimulating help-seeking than the ﬁrst screen [34]. In the base-
case analysis, we assumed that the effect of a rescreen after a
10-year interval would be similar to the effect of a rescreen after a
5-year interval and thus be lower than the effect of the ﬁrst
screen. Given the large time interval, however, this assumption
might not necessarily be true. We therefore reran the model, with
the effect of a rescreen after a 10-year interval being adapted to
equal the effect of the ﬁrst screen (one-way sensitivity analysis
4). Furthermore, we examined whether the results would have
been different if the future costs and effects had not been
discounted (one-way sensitivity analysis 5). In addition, we
performed a threshold analysis to determine the maximum costs
per screen at which the telephone and Internet screening
strategies would still be cost-effective compared with no
screening.Results
Base-Case Results
Table 1 presents the results of the probabilistic sensitivity
analysis. The incremental costs of the screening strategies
compared with no screening ranged from €4 to €59 and the
incremental QALYs ranged from 0.0003 to 0.0104. The ICERs of all
the screening strategies compared with current practice were
below €20,000/QALY, indicating that screening is cost-effective as
compared with no screening. HearCheck and audiometric screen-
ing strategies were dominated by telephone and Internet screen-
ing strategies. Telephone screening strategies were either
dominated or extendedly dominated by Internet screening
strategies. Only Internet screening strategies are on the cost-
effectiveness frontier (Fig. 2). With an ICER of €3699/QALY,
Internet screening at age 50 years, repeated at ages 55, 60, 65,
and 70 years, was the most cost-effective strategy at a ceiling
ratio of €20,000/QALY.
Figure 3 shows the CEAF. At λ values of €3000/QALY or lower,
current practice was the optimal strategy. At λ values between
€3000/QALY and €4500/QALY, the strategies that result in the
highest mean net monetary beneﬁt had a probability of being the
most cost-effective between 7% and 12%. At λ values between
€4,500/QALY and €20,000/QALY, Internet screening at age 50years, repeated at ages 55, 60, 65, and 70 years, was the optimal
strategy. At a threshold of €20,000/QALY, this strategy was
with 100% certainty cost-effective compared with current prac-
tice and with 69% certainty the most cost-effective among all
strategies.
One-Way Sensitivity Analyses
Lowering the probability of screen participation for Internet
screening from 0.44 to 0.33 decreased the incremental costs and
QALYs of Internet screening as compared with no screening. The
QALY gain by Internet screening at age 50 years with repetition at
ages 55, 60, 65, and 70 years became lower than the QALY gain by
the audiometric screening at age 50 years with repetition at ages
55, 60, 65, and 70 years, but the difference was only 0.0001 QALY,
while the incremental costs of the audiometric screening strategy
were twice as high as the incremental costs of the Internet
screening strategy (see Appendix Table A3 in Supplemental
Materials found at http://dx.doi.org/10.1016/j.jval.2015.03.1789).
Besides, the CEAF showed that Internet screening still had the
highest probability to be cost-effective (see Appendix Fig. A2.1 in
Supplemental Materials found at http://dx.doi.org/10.1016/j.jval.
2015.03.1789). The results of sensitivity analysis 2 to 4 were
similar to the results of the base-case analysis (see Appendix
Tables A4–A6 and Fig. A2.2–A2.4 in Supplemental Materials found
at http://dx.doi.org/10.1016/j.jval.2015.03.1789). Without discount-
ing future costs and effects, the cost-effectiveness frontier was
still formed by Internet screening strategies only but strategies
starting at age 50 years outperformed strategies that started later.
Internet screening at age 50 years, repeated at ages 55, 60, 65, and
70 years, was still the optimal strategy (see Appendix Table A7
and Fig. A2.5 in Supplemental Materials found at http://dx.doi.
org/10.1016/j.jval.2015.03.1789).
In the base case, the costs of the telephone screening were set
at €1.23 per screen (3.5 minutes at €0.35/min). Threshold analysis
on the screen costs showed that all telephone scenarios would
still be cost-effective compared with no screening when the costs
would have been €83.74 per screen. At €271.66 per screen, none of
the telephone screening scenarios was cost-effective compared
with no screening. In the base case, the annual costs of the
Internet screening were set at €144.47 (Webhosting). Depending
on the size of the target population and the participation rate, the
costs per screen were between € 0.0013 (for screening offered to
people aged 50 years) and €0.0026 (for screening offered to adults
aged 70 years). Threshold analysis showed that if the costs per
screen would have been €92.73, all Internet screening scenarios
would still be cost-effective compared with no screening. At
€320.49 per screen, none of the Internet screening scenarios
was cost-effective compared with no screening.Conclusions
Adult hearing screening was cost-effective compared with cur-
rent practice (no screening). Internet screening strategies were
the most cost-effective, closely followed by telephone screening
strategies. Internet screening probably outperformed telephone
screening because of its lower test costs and higher test sensi-
tivity and screen participation rate. Internet and telephone
screening probably outperformed HearCheck and audiometric
screening because of their lower test costs and accessibility for
people who do not annually visit the GP. Internet access hardly
forms a barrier for Internet screening nowadays in The Nether-
lands because 98% of adults aged between 45 and 55 years, 94% of
adults aged between 55 and 65 years, and 85% of adults aged
between 65 and 75 years have access to Internet at their home
[26].
Table 1 – Cost-effectiveness of adult hearing screening.
Screening strategy Costs (€) QALY Compared with no
screening
Conclusion
Type Age (y) Mean 95% CI Mean 95% CI Δ
Costs
Δ
QALY
ICER
No screening – 1054.95 684.56–
1613.25
17.6879 17.3809–
17.9877
HearCheck 70 1059.42 690.00–
1618.54
17.6888 17.3816–
17.9893
4.47 0.0009 4938 Extendedly
dominated
HearCheck 60 1059.74 689.07–
1619.68
17.6884 17.3813–
17.9886
4.79 0.0005 9187 Dominated
HearCheck 55 1059.81 689.17–
1620.30
17.6882 17.3813–
17.9882
4.87 0.0003 14143 Dominated
HearCheck 65 1059.97 690.14–
1619.09
17.6887 17.3815–
17.9892
5.03 0.0008 6157 Dominated
Telephone 70 1060.07 689.37–
1618.11
17.6895 17.3820–
17.9909
5.13 0.0017 3028 Extendedly
dominated
HearCheck 50 1060.56 689.66–
1620.90
17.6882 17.3812–
17.9885
5.61 0.0003 17466 Dominated
Telephone 65 1061.03 689.94–
1619.08
17.6897 17.3822–
17.9915
6.09 0.0018 3349 Extendedly
dominated
Telephone 60 1061.04 688.86–
1619.41
17.6895 17.3821–
17.9909
6.09 0.0016 3694 Dominated
Telephone 55 1061.54 688.96–
1620.84
17.6895 17.3818–
17.9912
6.60 0.0016 4014 Dominated
HearCheck 60, 70 1062.81 693.30–
1621. 47
17.6889 17.3819–
17.9898
7.86 0.0011 7315 Dominated
Internet 70 1062.89 692.15–
1617.75
17.6905 17.3827–
17.9914
7.94 0.0026 3024 Cost-effective
HearCheck 65, 70 1063.03 693.91–
1620.83
17.6892 17.3820–
17.9903
8.09 0.0014 5921 Dominated
Telephone 50 1063.04 690.15–
1624.46
17.6897 17.3819–
17.9918
8.10 0.0019 4340 Dominated
HearCheck 60, 65 1063.32 693.47–
1621.96
17.6889 17.3819–
17.9896
8.37 0.0010 8263 Dominated
HearCheck 55, 65 1063.38 693.45–
1622.29
17.6887 17.3817–
17.9891
8.43 0.0008 10063 Dominated
HearCheck 55, 60 1063.45 692.22–
1622.84
17.6885 17.3816–
17.9886
8.50 0.0007 12911 Dominated
Internet 60 1064.05 691.93–
1623.02
17.6903 17.3826–
17.9922
9.10 0.0025 3667 Dominated
HearCheck 50, 60 1064.17 692.88–
1624.19
17.6885 17.3815–
17.9886
9.23 0.0006 14495 Dominated
Internet 65 1064.27 692.74–
1620.34
17.6906 17.3828–
17.9923
9.32 0.0028 3337 Extendedly
dominated
HearCheck 50, 55 1064.42 692.98–
1624.46
17.6884 17.3814–
17.9887
9.48 0.0005 17906 Dominated
Internet 55 1064.60 692.05–
1625.29
17.6903 17.3827–
17.9921
9.65 0.0024 3975 Dominated
Telephone 65, 70 1065.05 692.75–
1622.08
17.6910 17.3830–
17.9927
10.11 0.0031 3215 Extendedly
dominated
Telephone 60, 70 1065.07 692.65–
1623.21
17.6908 17.3830–
17.9929
10.13 0.0030 3398 Dominated
Telephone 60, 65 1065.76 692.82–
1624.45
17.6909 17.3830–
17.9930
10.82 0.0030 3551 Dominated
Telephone 55, 60 1066.18 692.20–
1628.35
17.6907 17.3829–
17.9930
11.24 0.0029 3913 Dominated
Telephone 55, 65 1066.28 693.41–
1627.31
17.6909 17.3829–
17.9931
11.34 0.0030 3722 Dominated
HearCheck 60, 65, 70 1066.39 697.19 to
1626.42
17.6894 17.3824 to
17.9906
11.44 0.0016 7319 Dominated
Internet 50 1066.69 693.17–
1628.83
17.6906 17.3828–
17.9932
11.75 0.0027 4298 Dominated
continued on next page
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Table 1 – continued
Screening strategy Costs (€) QALY Compared with no
screening
Conclusion
Type Age (y) Mean 95% CI Mean 95% CI Δ
Costs
Δ
QALY
ICER
HearCheck 55, 60, 65 1067.02 697.00–
1627.88
17.6890 17.3822–
17.9897
12.08 0.0012 10501 Dominated
HearCheck 50, 60, 70 1067.24 697.33–
1628.37
17.6890 17.3823–
17.9897
12.29 0.0012 10331 Dominated
Telephone 50, 60 1067.70 693.51–
1630.87
17.6910 17.3826–
17.9933
12.75 0.0031 4117 Dominated
Telephone 50, 55 1067.99 693.45–
1631.63
17.6909 17.3826–
17.9933
13.04 0.0031 4266 Dominated
HearCheck 50, 55, 60 1068.06 695.99–
1630.07
17.6887 17.3819–
17.9889
13.11 0.0008 15549 Dominated
Telephone 60, 65, 70 1069.77 696.77–
1629.46
17.6922 17.3837–
17.9945
14.83 0.0044 3394 Extendedly
dominated
HearCheck 55, 60, 65,
70
1070.09 700.55–
1630.28
17.6896 17.3827–
17.9906
15.14 0.0017 8907 Dominated
Internet 60, 70 1070.11 697.62 to
1627.88
17.6924 17.3838 to
17.9956
15.17 0.0045 3369 Extendedly
dominated
Internet 65, 70 1070.29 698.70–
1626.66
17.6927 17.3839–
17.9956
15.34 0.0048 3197 Cost-effective
Telephone 55, 60, 65 1070.90 696.47–
1633.20
17.6921 17.3836–
17.9950
15.96 0.0043 3739 Dominated
Internet 60, 65 1071.06 697.93–
1629.75
17.6924 17.3838–
17.9959
16.12 0.0046 3512 Dominated
Internet 55, 60 1071.32 697.04–
1633.83
17.6921 17.3838–
17.9956
16.37 0.0043 3850 Dominated
Audiometry 55 1071.57 697.85–
1636.87
17.6893 17.3821–
17.9904
16.63 0.0014 11607 Dominated
HearCheck 50, 55, 60,
65
1071.63 700.55–
1632.74
17.6892 17.3825–
17.9896
16.69 0.0013 12500 Dominated
Internet 55, 65 1071.65 697.69–
1631.41
17.6924 17.3839–
17.9962
16.70 0.0045 3674 Dominated
Telephone 50, 60, 70 1071.73 696.84–
1634.65
17.6923 17.3836–
17.9952
16.79 0.0044 3791 Dominated
Audiometry 60 1072.15 698.35–
1635.88
17.6900 17.3826–
17.9911
17.21 0.0022 7871 Dominated
Telephone 50, 55, 60 1072.62 696.72–
1636.92
17.6921 17.3833–
17.9953
17.68 0.0043 4127 Dominated
Audiometry 70 1072.90 700.53–
1632.68
17.6916 17.3830–
17.9930
17.96 0.0037 4845 Dominated
Internet 50, 60 1073.44 697.78–
1638.90
17.6924 17.3839–
17.9963
18.50 0.0046 4051 Dominated
Audiometry 50 1073.54 699.17–
1644.11
17.6892 17.3822–
17.9901
18.59 0.0013 14162 Dominated
Internet 50, 55 1073.69 697.65–
1640.50
17.6923 17.3837–
17.9964
18.75 0.0045 4188 Dominated
Audiometry 65 1074.42 701.10–
1634.80
17.6913 17.3830–
17.9924
19.48 0.0034 5702 Dominated
HearCheck 50, 55, 60,
65, 70
1074.70 704.20–
1634.19
17.6897 17.3829–
17.9905
19.75 0.0019 10479 Dominated
Telephone 55, 60, 65,
70
1074.91 700.72–
1635.46
17.6934 17.3838–
17.9970
19.97 0.0056 3572 Extendedly
dominated
Internet 60, 65, 70 1077.08 702.83–
1637.42
17.6944 17.3850–
17.9982
22.13 0.0066 3358 Cost-effective
Telephone 50, 55, 60,
65
1077.34 700.93–
1640.30
17.6935 17.3838–
17.9974
22.39 0.0057 3944 Dominated
Internet 55, 60, 65 1078.32 702.41–
1641.64
17.6942 17.3848–
17.9981
23.38 0.0064 3678 Dominated
continued on next page
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Table 1 – continued
Screening strategy Costs (€) QALY Compared with no
screening
Conclusion
Type Age (y) Mean 95% CI Mean 95% CI Δ
Costs
Δ
QALY
ICER
Internet 50, 60, 70 1079.50 703.63–
1645.43
17.6944 17.3852–
17.9983
24.56 0.0066 3729 Dominated
Internet 50, 55, 60 1080.40 702.33–
1649.67
17.6942 17.3849–
17.9987
25.45 0.0063 4042 Dominated
Telephone 50, 55, 60,
65, 70
1081.34 704.84–
1642.77
17.6949 17.3845–
17.9997
26.40 0.0070 3772 Extendedly
dominated
Audiometry 55, 60 1081.38 705.12–
1649.94
17.6907 17.3832–
17.9918
26.44 0.0028 9324 Dominated
Audiometry 60, 70 1082.33 708.54–
1646.09
17.6924 17.3838–
17.9943
27.39 0.0046 5975 Dominated
Audiometry 55, 65 1082.67 708.39–
1649.31
17.6915 17.3835–
17.9925
27.73 0.0036 7607 Dominated
Audiometry 50, 55 1082.89 706.58–
1657.62
17.6901 17.3832–
17.9908
27.95 0.0022 12544 Dominated
Audiometry 50, 60 1083.13 706.49–
1655.95
17.6906 17.3833–
17.9913
28.19 0.0027 10338 Dominated
Audiometry 60, 65 1083.47 709.07–
1647.56
17.6922 17.3838–
17.9942
28.52 0.0044 6515 Dominated
Internet 55, 60, 65,
70
1084.33 707.71–
1649.43
17.6962 17.3860–
18.0004
29.38 0.0084 3516 Cost-effective
Audiometry 65, 70 1084.54 711.28–
1644.93
17.6936 17.3842–
17.9963
29.60 0.0058 5119 Dominated
Internet 50, 55, 60,
65
1087.39 707.29–
1658.82
17.6963 17.3862–
18.0015
32.44 0.0084 3865 Extendedly
dominated
Audiometry 55, 60, 65 1092.64 715.32–
1662.23
17.6929 17.3844–
17.9946
37.69 0.0050 7495 Dominated
Audiometry 50, 55, 60 1092.73 713.99–
1667.79
17.6915 17.3843–
17.9926
37.78 0.0036 10408 Dominated
Audiometry 50, 60, 70 1093.26 715.71 to
1664.86
17.6930 17.3853 to
17.9946
38.31 0.0051 7473 Dominated
Internet 50, 55, 60,
65, 70
1093.39 712.99–
1665.27
17.6982 17.3878–
18.0048
38.45 0.0104 3699 Cost-effective
Audiometry 60, 65, 70 1093.65 717.87–
1658.41
17.6946 17.3850–
17.9982
38.70 0.0067 5736 Dominated
Audiometry 55, 60, 65,
70
1102.81 724.24–
1672.98
17.6953 17.3863–
17.9990
47.86 0.0074 6468 Dominated
Audiometry 50, 55, 60,
65
1103.96 723.53–
1678.71
17.6937 17.3861–
17.9959
49.02 0.0058 8417 Dominated
Audiometry 50, 55, 60,
65, 70
1114.12 734.06–
1690.29
17.6960 17.3878–
17.9995
59.18 0.0082 7222 Dominated
CI, conﬁdence interval; ICER, incremental cost-effectiveness ratio; QALY, quality-adjusted life-year.
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for an audiometric screening at age 60 years, repeated at ages 65
and 70 years, compared with current practice in the United
Kingdom. In our study, the ICER of this strategy was €5736/QALY
(dominated by Internet screening at age 50, 55, 60, 65, and 70
years). The difference in the ICER might be caused by differences
in model input estimates. For example, the costs of a hearing aid
trial and a hearing aid are much higher in The Netherlands than
in the United Kingdom, and the probability of hearing aid uptake
might be lower because Dutch patients have to pay a substantial
amount of money for a hearing aid (on average €600 in 2011),
whereas most patients in the United Kingdom receive hearing
aids for free. Differences in model structure probably contribute
to the discrepancy between the ICERs as well. We modeledscreening programs for the detection of a best-ear pure-tone
average hearing loss (at 0.5, 1, 2, and 4 kHz) of 25 dB or more,
whereas Morris et al.’s screening program aimed to detect a
hearing loss of 30 dB or more. And unlike Morris et al. [20], we
included the costs of care given to people who consult a hearing
care professional or even start a hearing aid trial but do not take
up hearing aids. Our study showed that in a more expensive
hearing care system, audiometric screening is cost-effective
compared with no screening. Internet screening, however, is
the most cost-effective approach.
Liu et al. [19] reported that adult hearing screening using a
handheld screening device is cost-effective. They based their
conclusion on a randomized controlled trial that showed that
screening led to a signiﬁcant increase in hearing aid use 1 year
Fig. 2 – Cost-effectiveness plane. The incremental costs and
quality-adjusted life-years of telephone screening (stars),
Internet screening (circles), HearCheck screening (triangles),
and audiometric screening (squares) compared with no
screening are presented. The line represents the cost-
effectiveness frontier. The ﬁgure is based on the results of
the probabilistic sensitivity analysis.
V A L U E I N H E A L T H 1 8 ( 2 0 1 5 ) 5 6 0 – 5 6 9 567later (2.8%). The incremental costs of screening per additional
hearing aid user were US $1439 (€1040). It cannot be concluded
from this trial, however, whether screening is indeed cost-
effective because it is unknown how much society is willing to
pay for one additional hearing aid user. So far, it has only been
assessed how much society is willing to pay for QALYs gained.
Other limitations of this trial are the short follow-up period and
the fact that it included particularly male veterans, a study
sample that may not be representative for the total adult
population. By using a Markov model we were able to calculate
the lifetime costs and effects of screening for a general popula-
tion cohort. And because we measured the effectiveness in terms
of QALYs gained, we could draw conclusions with regard to the
cost-effectiveness of a large number of screening strategies.
Our study has several limitations. Bias may be introduced by
the fact that the model parameter estimates were derived from
several sources, none of which was a randomized controlled trial.
The probabilities of screen participation for telephone screening,
Internet screening, and screening at the GP, and some of the
probabilities of help-seeking after screening, however, were all
derived from one study [33]. The assumptions we had to make
about some of the parameter estimates due to a lack of evidenceFig. 3 – Cost-effectiveness acceptability fromay have biased the results as well. With probabilistic sensitivity
analysis, however, we accounted for the uncertainty in the
estimates by assigning wide distributions to the model parame-
ters and one-way sensitivity analyses showed that the results
were insensitive to the assumptions we were most uncertain
about. A second limitation is that the costs of management,
quality control, and monitoring of the screening strategies were
not taken into account. Because these costs will be similar for all
screening strategies, inclusion of these costs would not have
changed the strategy ranking. Inclusion of these costs, however,
would have resulted in higher ICERs of the screening strategies
compared with no screening. Post hoc threshold analysis of
strategy costs revealed that the strategy with Internet screening
at age 50, 55, 60, 65, and 70 years would still be cost-effective if
the incremental costs of the strategy (compared with no screen-
ing) would increase from €38 to €208. Based on this, it also seems
plausible that when the costs of management, quality control,
and monitoring are taken into account, the screening strategy
will be cost-effective. A third limitation of the study is that the
model disregarded rehabilitation options other than conventional
hearing aids, such as communication training or assistive listen-
ing devices. In most previous studies on adult hearing screening,
rehabilitation was limited to hearing aid ﬁtting [35]. Conse-
quently, data on the effect of screening on the uptake of other
rehabilitation options were insufﬁcient to incorporate in the
model, as were data on quality-of-life gain by other rehabilitation
options. Future research to address this topic is recommended.
The utility estimates used in the model were based on the
Health Utility Index Mark 3 questionnaire. This is the recom-
mended instrument for measuring utility scores to assess health-
related quality of life in hearing impairment because of its good
validity and responsiveness [36]. Other multiattribute utility
instruments, such as the Health Utilities Index Mark 2, the
EuroQol ﬁve-dimensional questionnaire, and the six-dimen-
sional health state short form (derived from short-form 36 health
survey), are less sensitive to changes in utility scores after
hearing aid ﬁtting or even unable to measure a change at all
[28,37,38]. If another multiattribute utility instrument had been
used, adult hearing screening may not have been cost-effective.
Although we used the most sensitive utility instrument, the
screening strategies led to only a little gain in quality of life
(0.0003–0.0104 QALYs). QALY gains from population screening
programs generally tend to be quite modest [39,40], probably
because the effect of treatment is diluted by the large number of
healthy people in the target population for whom no quality-of-
life gain can be achieved.
To what extent our results can be generalized and transferred
to other countries depends on international similarities and
differences with regard to health care system and culture. For
example, hearing aid uptake after screening may be higher inntier. QALY, quality-adjusted life-year.
V A L U E I N H E A L T H 1 8 ( 2 0 1 5 ) 5 6 0 – 5 6 9568countries where hearing aids are provided free of charge, as in
the United Kingdom or Denmark. And in countries where
patients’ ﬁnancial contribution to hearing aids is higher than in
The Netherlands, for example, in Belgium, screening will prob-
ably be less cost-effective because the high hearing aid costs may
withhold screen participants from taking up hearing aids. Also,
the likelihood to participate in hearing screening differs between
countries. Koopman et al. [33] found that compared with Dutch
adults, British and German adults were much more likely to do a
telephone test (50% and 76% vs. 33%) or an Internet test (65% and
73% vs. 44%). And although Dutch and British adults were found
to be equally likely to opt for additional hearing testing after a
positive screen (80%), the Germans were much more likely to do
so (95%) [33]. Furthermore, the effectiveness of Internet screen-
ing will depend on the proportion of adults in the target
population who have Internet access at home. The Netherlands
is leading in Europe, with 95% of the households having Internet
access, followed by Luxembourg (94%), Denmark, and Sweden
(both 93%). Internet access in Europe is lowest in Bulgaria (54%),
Greece (56%), and Romania (58%) [41].
In conclusion, this study suggests that nationwide adult
hearing screening programs are (in comparison with no screen-
ing) cost-effective interventions to increase the quality of life of
adults with hearing loss, with Internet screening at age 50 years,
repeated at ages 55, 60, 65, and 70 years, being the optimal
strategy. Because at a threshold of €20,000/QALY this strategy
was with 100% certainty cost-effective compared with current
practice and with 69% certainty the most cost-effective among all
strategies, policymakers might consider nationwide implemen-
tation. Telephone screening is a good alternative for people
without Internet access.
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